Table 3 Factors associated with CLEC18 levels in the patients with CHB
Variables | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|
Parameter Estimate | Standard Error | T Value | P Value | Parameter Estimate | Standard Error | T Value | P Value | |
Age | −18.41386 | 5.17495 | −3.56 | 0.0004 | −11.3821 | 6.1275 | −1.86 | 0.0644 |
Sex: Man vs Woman | −25.76591 | 128.98391 | −0.20 | 0.8418 | ||||
Genotype: C vs B | 29.89732 | 126.53368 | 0.24 | 0.8134 | ||||
HBeAg: (+) vs (−) | 428.94574 | 120.57574 | 3.56 | 0.0004 | 194.63847 | 162.600 | 1.20 | 0.2324 |
HBsAg log10 IU/mL | 189.40927 | 67.77183 | 2.79 | 0.0056 | 20.737 | 91.28661 | 0.23 | 0.8205 |
HBV DNA log10 IU/mL | 85.07892 | 27.25278 | 3.12 | 0.0020 | 25.6009 | 40.78698 | 0.63 | 0.5308 |
Cirrhosis: Yes vs No | − 142.57582 | 126.72962 | −1.13 | 0.2616 | ||||
Fatty liver: Yes vs No | −38.09601 | 119.31101 | −0.32 | 0.7497 | ||||
ALT: IU/L | 0.30495 | 0.14451 | 2.11 | 0.0358 | 0.09404 | 0.16072 | 0.59 | 0.5590 |
Total bilirubin: mg/dL | −5.61291 | 45.41720 | −0.12 | 0.9017 | ||||
Platelet: × 103 /μL | 1.16809 | 0.97747 | 1.20 | 0.2331 | ||||
PT: seconds prolonged | −19.80886 | 31.83170 | −0.62 | 0.5343 | ||||
Cr: mg/dL | 17.03954 | 124.23906 | 0.14 | 0.8910 | ||||
AFP: ng/mL | 0.99144 | 0.79197 | 1.25 | 0.2117 | ||||
METAVIR Activity grade 2, 3 vs 0, 1 | − 102.09187 | 167.92687 | −0.61 | 0.5441 | ||||
METAVIR Fibrosis stage 3, 4 vs 0–2 | − 303.34073 | 171.59770 | −1.77 | 0.0791 | ||||